MedPlus Health Q1 FY27 profit drops 22% to ₹33 crore despite 21.8% revenue surge
Synopsis
MedPlus Health grew revenues by nearly 22% in Q1 FY27 but saw net profit shrink by the same margin — a classic expansion paradox. With 146 new stores added and ₹155 crore in fresh Hyderabad investments announced, the company is betting on scale and diversification while margins remain under visible pressure.
Key Takeaways
MedPlus Health reported a net profit of ₹33 crore in Q1 FY27 , down 21.8 per cent YoY from ₹42 crore in Q1 FY26.
Revenue from operations rose 21.8 per cent to ₹1,879.6 crore , up from ₹1,542.6 crore a year ago.
EBITDA margin contracted to 7.1 per cent from 8.5 per cent ; gross margin fell 160 basis points to 24.5 per cent .
The company added 146 new stores in the quarter, including 131 franchisee outlets .
Subsidiary Optival Health Solutions plans a ₹40 crore food park and a ₹115 crore wellness facility, both in Hyderabad .
Shares closed at ₹802.40 on the BSE , up 0.18 per cent on the day of results.
MedPlus Health Services Limited posted a 21.8 per cent year-on-year decline in consolidated net profit for the first quarter of FY27, even as revenues expanded at a matching pace. The pharmacy retail chain earned a net profit of ₹33 crore in the April–June 2025 quarter, down from ₹42 crore in Q1 FY26, according to its stock exchange filing. The divergence between top-line growth and bottom-line compression signals mounting cost pressure across the business.
Revenue Growth Masks Margin Squeeze
Revenue from operations climbed 21.8 per cent YoY to ₹1,879.6 crore, up from ₹1,542.6 crore in the year-ago quarter — a strong headline number. However, profitability told a different story. EBITDA rose only marginally by 1.9 per cent to ₹133.2 crore from ₹130.7 crore, while the EBITDA margin contracted sharply to 7.1 per cent from 8.5 per cent a year earlier.
The company's gross margin narrowed by 160 basis points to 24.5 per cent, down from 26.1 per cent in Q1 FY26. Operating EBITDA fell further, declining to ₹65.1 crore from ₹72.8 crore, with the operating EBITDA margin slipping to 3.5 per cent from 4.7 per cent. The pattern suggests that aggressive store expansion is absorbing a significant share of incremental revenues.
Store Expansion Continues at Pace
MedPlus added 146 new stores during the quarter, of which 131 were franchisee outlets, reinforcing its strategy of asset-light network growth across key markets. The expansion widens its retail footprint but also introduces near-term overhead costs that are compressing margins at the operating level. This is consistent with a growth-over-profitability posture that the company has maintained over recent quarters.
Fresh Investments in Telangana Signal Diversification
Alongside its quarterly results, MedPlus announced two significant capital allocation decisions in Hyderabad. Its material subsidiary, Optival Health Solutions Private Limited, intends to establish a food park in Hyderabad that will include a cold press oil extraction unit, with an estimated investment of ₹40 crore covering land development, construction, machinery, utilities, and filling and packing lines.
Separately, the company plans to set up a Concierge Health and Wellness Services Facility in Hyderabad, offering preventive healthcare, diagnostics, specialist consultations, and wellness services through a subscription-based membership model. The proposed centre carries a total investment of approximately ₹115 crore, including capital expenditure of ₹90 crore. Together, these moves suggest MedPlus is pivoting beyond pure pharmacy retail toward a broader healthcare ecosystem play.
Stock Performance and Market Context
Shares of MedPlus Health Services Limited closed at ₹802.40 on the BSE on Tuesday, gaining ₹1.45, or 0.18 per cent, ahead of the earnings announcement. The muted stock movement reflects a market that had already priced in the revenue growth story while remaining cautious about the margin trajectory. With two large capital projects now in the pipeline, investor focus is likely to shift toward execution timelines and return on invested capital in the quarters ahead.
Point of View
Margins thinning faster. A 160-basis-point gross margin erosion alongside a 21.8 per cent revenue jump suggests the new stores are dilutive at the unit-economics level, at least in their early months. The pivot into food parks and subscription wellness in Hyderabad is strategically interesting but adds execution risk to a business already under margin pressure. The market's near-indifference — a 0.18 per cent stock gain on results day — signals that investors want to see margin recovery before re-rating the stock.
NationPress
22 Jul 2026
Frequently Asked Questions
What were MedPlus Health's Q1 FY27 earnings results?
MedPlus Health reported a net profit of ₹33 crore for Q1 FY27 (April–June 2025), a 21.8 per cent decline from ₹42 crore in Q1 FY26. Revenue from operations grew 21.8 per cent to ₹1,879.6 crore, but margins contracted across all key metrics.
Why did MedPlus profit fall despite strong revenue growth?
Profitability came under pressure from margin compression: the EBITDA margin fell to 7.1 per cent from 8.5 per cent, and the gross margin narrowed by 160 basis points to 24.5 per cent. Rapid store expansion — 146 new outlets in a single quarter — is absorbing incremental revenues and weighing on operating profitability.
What new investments has MedPlus announced in Hyderabad?
MedPlus, through subsidiary Optival Health Solutions, plans to invest ₹40 crore in a food park with a cold press oil extraction unit in Hyderabad. It also plans a ₹115 crore Concierge Health and Wellness Services Facility offering diagnostics, specialist consultations, and preventive care on a subscription model.
How many stores did MedPlus add in Q1 FY27?
MedPlus added 146 new stores during the April–June 2025 quarter, of which 131 were franchisee outlets, continuing its asset-light network expansion strategy across key markets.
How did MedPlus shares perform on results day?
Shares of MedPlus Health Services closed at ₹802.40 on the BSE on Tuesday, up ₹1.45 or 0.18 per cent, ahead of the earnings announcement — a muted reaction reflecting investor caution on the margin outlook.
